Interleukin-23 Antagonist
7 drugs across 2 manufacturers|0 Generic,7 Brand
The Interleukin-23 Antagonist class contains 7 NDCs from 2 manufacturers (0 generic, 7 brand), at an average NADAC of $20308.76 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
7
0G / 7B
Manufacturers
2
Avg $20308.7629/unit
Avg 7d Change
-0.12%
Across 1 drugs with changes
7d Activity
of 7 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Interleukin-23 Antagonist class?
The Interleukin-23 Antagonist class contains 7 NDCs from 2 manufacturers — 0 generic and 7 brand products.
What is the average price of Interleukin-23 Antagonist drugs?
The average NADAC for the Interleukin-23 Antagonist class is $20308.7629 per unit across 7 NDCs.
Which manufacturers make Interleukin-23 Antagonist drugs?
2 manufacturers make drugs in the Interleukin-23 Antagonist class. Ranked by number of NDCs, the largest are Janssen Biotech, Inc. (5), AbbVie Inc. (2).
How has Interleukin-23 Antagonist pricing changed recently?
Over the past 7 days, 0 NDCs in this class rose and 1 fell, with a class-wide average change of -0.1%.
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
STELARA 45 MG/0.5 ML SYRINGE ustekinumab | $29841.6480 per ML | — |
STELARA 90 MG/ML SYRINGE ustekinumab | $29797.8880 per ML | — |
SKYRIZI 150 MG/ML SYRINGE risankizumab-rzaa | $22942.3716 per ML | — |
SKYRIZI 150 MG/ML PEN risankizumab-rzaa | $22710.1121 per ML | -0.12% |
TREMFYA 100 MG/ML SYRINGE Guselkumab | $14779.6320 per ML | — |
TREMFYA 100 MG/ML ONE-PRESS Guselkumab | $14740.0180 per ML | — |
TREMFYA 200 MG/2 ML PEN guselkumab | $7349.6703 per ML | — |